Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00085774 · ClinicalTrials.gov registry record · Phase 3
Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma
A Phase 3 study, sponsored by Teva Branded Pharmaceutical Products R&D.
- Completed
- Registry status
- Phase 3
- Development phase
- 24
- Enrollment target
NCT00085774 is a Phase 3 study that has completed, run by Teva Branded Pharmaceutical Products R&D. The registered enrollment target is 24 participants.
The verdict
NCT00085774, a Phase 3 study, has completed, sponsored by Teva Branded Pharmaceutical Products R&D.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 24 participants
- Enrollment target
Study Summary
This study was designed to examine the effectiveness of two bronchodilator inhalers in patients who have exercise-induced asthma.
Interventions
- DRUG albuterol aerosol by HFA MDI
- DRUG albuterol aerosol by HFA BOI
- DRUG placebo aerosol by HFA
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2004-06-30 |
| Est. Completion | 2004-09-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00085774
The ClinicalTrials.gov registry entry for NCT00085774 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Teva Branded Pharmaceutical Products R&D, which has 167 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which albuterol aerosol by HFA MDI is the first listed.
NCT00085774 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00085774 about?
NCT00085774 is a clinical study titled "Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma". This study was designed to examine the effectiveness of two bronchodilator inhalers in patients who have exercise-induced asthma.
What is the current status of trial NCT00085774?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 24 participants. The study started on 2004-06-30. Estimated completion is 2004-09-30.
What interventions are being tested in trial NCT00085774?
The interventions under investigation include: albuterol aerosol by HFA MDI (DRUG), albuterol aerosol by HFA BOI (DRUG), placebo aerosol by HFA (DRUG).
Who is sponsoring clinical trial NCT00085774?
This trial is sponsored by Teva Branded Pharmaceutical Products R&D, which has 167 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.